This article is more than 5 years old. Information may no longer be current.

Carl Zeiss Meditec reports 18.6% year-to-year revenue increase in first quarter

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

JENA, Germany — Carl Zeiss Meditec reported consolidated revenue of €185.2 million for the first quarter of 2010-2011, an 18.6% increase over the first quarter of the previous year, according to a press release from the company.

"Based on the encouraging sales in the first quarter, we are feeling extremely optimistic about the financial year ahead and are aiming for revenue of between €720 million and €750 million — provided trends in the regions do not change and there is no currency-related turbulence," Ludwin Monz, PhD, Carl Zeiss Meditec president and CEO, said in the release.

The boost in first-quarter revenue was attributed to positive currency effects and robust earnings in the ophthalmic systems and microsurgery strategic business units, the release said.

Revenue exceeded the previous year by 31.9% in the Asia-Pacific region, 19.3% in the Americas region and 8.6% in the Europe-Middle East-Africa region.

Year-to-year, first-quarter revenue increased 21.8% in the microsurgery sector, 20.5% in ophthalmic systems and 1% in surgical ophthalmology.

Ophthalmic systems comprised 47.6% of consolidated revenue. Top-selling products in this sector were refractive laser systems and the Cirrus HD-OCT.

Zeiss invested €19.3 million in research and development, an increase of €3.1 million over the first quarter of 2009-2010.

"In the current financial year, Carl Zeiss Meditec shall intensify its research activities in growth markets and, with its own application and research center in India, shall work even more closely with its customers on site," the release said.